Tango Therapeutics (TNGX) Total Current Liabilities (2020 - 2026)
Tango Therapeutics (TNGX) posted quarterly Total Current Liabilities of $14.3 million for Q1 2026, down 60.1% year-over-year from $35.9 million in Q1 2025, and down 33.9% quarter-over-quarter from $21.7 million in Q4 2025.
Tango Therapeutics (TNGX) Total Current Liabilities (2020 - 2026) Analysis & Trends
Tango Therapeutics' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $14.3 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 60.1% year-over-year to $14.3 million; the TTM figure through Mar 2026 stood at $14.3 million (down 60.1% YoY), while the FY2025 annual figure was $21.7 million, down 43.2% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $14.3 million, down from $21.7 million in the prior quarter.
- The five-year high for Total Current Liabilities was $55.5 million in Q4 2022, with the low at $14.3 million in Q1 2026.
- The 5-year median for Total Current Liabilities is $42.8 million (2024), against an average of $40.0 million.
- The sharpest annual moves came in 2022 and 2026: Total Current Liabilities surged 12885.32% in 2022, then sank 60.1% in 2026.
- Tango Therapeutics' Total Current Liabilities stood at $55.5 million in 2022, then dropped by 17.3% to $45.9 million in 2023, then dropped by 16.91% to $38.2 million in 2024, then tumbled by 43.2% to $21.7 million in 2025, then plunged by 33.9% to $14.3 million in 2026.
- Business Quant data shows TNGX's Total Current Liabilities at $14.3 million in Q1 2026, $21.7 million in Q4 2025, and $18.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Tango Therapeutics | 4.32 Bn | 3.30 Bn | - | 20.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.30 Mn |
| Mar 31, 2026 | 14.33 Mn |
| Dec 31, 2025 | 21.68 Mn |
| Sep 30, 2025 | 18.44 Mn |
| Jun 30, 2025 | 40.03 Mn |
| Mar 31, 2025 | 35.92 Mn |
| Dec 31, 2024 | 38.17 Mn |
| Sep 30, 2024 | 37.58 Mn |
| Jun 30, 2024 | 43.87 Mn |
| Mar 31, 2024 | 42.79 Mn |
| Dec 31, 2023 | 45.94 Mn |
| Sep 30, 2023 | 43.42 Mn |
| Jun 30, 2023 | 53.63 Mn |
| Mar 31, 2023 | 53.67 Mn |
| Dec 31, 2022 | 55.55 Mn |
| Sep 30, 2022 | 51.32 Mn |
| Jun 30, 2022 | 44.68 Mn |
| Mar 31, 2022 | 39.21 Mn |
| Dec 31, 2021 | 40.69 Mn |
| Sep 30, 2021 | 41.99 Mn |